Thank you, Mr. Chair.
Thank you to the pharmaceutical companies for being here today.
Ms. Sampson, in your opening statement you said that you believed that parliamentary oversight has already occurred.
Could you explain how that's possible, given that parliamentarians haven't seen the contracts yet?